• Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 24 Nov 2024 02:31:09   America/New_York


    Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat November 24, 2024 Share Link copied to clipboard. Shares of Regeneron Pharmaceuticals, Inc.
    Read more...
Share on,